The Weill Cornell Medicine (WCM) Clinical Genomics Lab enables our doctors and scientists to utilize advanced gene sequencing technologies to identify the genetic alterations that give rise to and drive disease.
Our laboratory is structured to provide high-quality, targeted patient results quickly and accurately. We integrate the latest sequencing technology with the expertise of a collaborative team comprised of board-certified, specialized pathologists, computational biologists and physician-scientists to assist clinicians in determining the best possible treatment plans for their patients.
Our genomic pathology services are targeted and individualized for each patient based on specific genetic profiles and medical history. We diagnose diseases through the examination of biological samples, including blood samples that are analyzed for the study of diseases such as leukemia and lymphoma, and tissue samples that are used to analyze solid tumors.
We also collaborate with our WCM Englander Institute for Precision Medicine partners to study genetic disease drivers. Their databases, including the Precision Medicine Knowledge Base (PMKB), help clinicians determine which drugs or drug combinations will be most effective for each patient. We continue to build on precision medicine research and translate highly scientific information to make it actionable for doctors and their patients in a clinical setting.
The WCM Pathology & Laboratory Medicine Clinical Genomics Laboratory is New York State (NYS) Clinical Laboratory Improvement Amendment (CLIA)-certified and fully accredited by the College of American Pathologists (CAP), the leading advocate of excellence in the practice of pathology and laboratory medicine worldwide.